JPRN-UMIN000024564已完成2 期
Efficacy and safety of epicutaneous immunotherapy for severe milk allergy - Epicutaneous immunotherapy for milk allergy
ational Hospital Organization Mie National Hospital0 个研究点目标入组 46 人开始时间: 2016年11月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 46
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2years-old 至 15years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)patients whose intake levels of milk changed within 3 months of the trial 2)patients who had milk oral immunotherapy within 6 months 3) patients who are on other immunotherapy 4)patients who have heart, liver and kidney diseases 5)patients with ncontrolled asthma or atopic dermatitis
研究者
相似试验
招募中
2 期
Epicutaneous Immunotherapy for Egg AllergyEgg allergyEgg allergy, epicutaneous immunotherapyJPRN-jRCTs031200307Iwai Fumiko63
已完成
2 期
Efficacy and safety of epicutaneous immunotherapy for severe egg allergyFood allergyJPRN-UMIN000022348ational Hospital Organization Mie National Hospital40
已完成
2 期
Efficacy and safety of epicutaneous immunotherapy for severe egg allergy; Long term trialFood allergyJPRN-UMIN000025381ational Hospital Organization Mie National Hospital20
已完成
2 期
Efficacy and safety of epicutaneous immunotherapy for severe milk allergy; Long term trialFood allergyJPRN-UMIN000027459ational Hospital Organization Mie National Hospital46
尚未招募
不适用
Efficacy of the epicutaneous immunotherapy for food allergy -Selection of skin sticking device and allergenmilk allergyJPRN-UMIN000037562Tokai University Hachioji Hospital40